Form 8-K/A - Current report: [Amend]
SEC Accession No. 0001193125-16-513640
Filing Date
2016-03-22
Accepted
2016-03-22 17:24:33
Documents
5
Period of Report
2016-01-08
Items
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K/A d137565d8ka.htm 8-K/A 16539
2 EX-2.1 d137565dex21.htm EX-2.1 2009
3 EX-99.1 d137565dex991.htm EX-99.1 253314
4 EX-99.2 d137565dex992.htm EX-99.2 209179
5 GRAPHIC g137565g0322064614129.jpg GRAPHIC 3164
  Complete submission text file 0001193125-16-513640.txt   486660
Mailing Address 11119 NORTH TORREY PINES ROAD SUITE 200 LA JOLLA CA 92037
Business Address 11119 NORTH TORREY PINES ROAD SUITE 200 LA JOLLA CA 92037 858-550-7500
LIGAND PHARMACEUTICALS INC (Filer) CIK: 0000886163 (see all company filings)

EIN.: 770160744 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K/A | Act: 34 | File No.: 001-33093 | Film No.: 161521800
SIC: 2834 Pharmaceutical Preparations